ALNY AS OF 12/31/2013

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

February 12, 2014

Accession Number

0000080255-14-000428

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →